Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Colletti

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Clinical Nuclear Medicine|February 28, 2018
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?Pilar Perlaza, Jaime Ortín, Mario Pagès, et al.
Clinical Nuclear Medicine|January 31, 2016
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic ReviewKa Kit Wong, Barbra S Miller, Benjamin L Viglianti, et al.
Clinical Nuclear Medicine|September 5, 2014
11C-choline PET/CT for restaging of bladder cancerTiziano Graziani, Francesco Ceci, Flavia Lobo Lopes, et al.
Clinical Nuclear Medicine|December 16, 2020
Novel Experience in Hybrid Tracers: Clinical Evaluation of Feasibility and Efficacy in Using ICG-99mTc Nanotop for Sentinel Node Procedure in Breast Cancer PatientsGianpiero Manca, Ludovico Maria Garau, Sara Mazzarri, et al.
Clinical Nuclear Medicine|February 3, 2015
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approachR A Werner, Christina Bluemel, M Lassmann, et al.
Clinical Nuclear Medicine|February 3, 2021
Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple MyelomaNieves Gómez León, Beatriz Aguado Bueno, María Herreros Pérez, et al.
Clinical Nuclear Medicine|May 24, 2013
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT studyFrancesco Ceci, Riccardo Schiavina, Paolo Castellucci, et al.
Clinical Nuclear Medicine|December 26, 2015
18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With TuberculosisIngrid Stelzmueller, Helmut Huber, Rainer Wunn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2013
Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapyAnna Margherita Maffione, Alice Ferretti, Gaia Grassetto, et al.
Clinical Nuclear Medicine|June 26, 2013
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mLMarcelo Mamede, Francesco Ceci, Paolo Castellucci, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Clinical Nuclear Medicine|February 28, 2018
Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?Pilar Perlaza, Jaime Ortín, Mario Pagès, et al.
Clinical Nuclear Medicine|January 31, 2016
Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic ReviewKa Kit Wong, Barbra S Miller, Benjamin L Viglianti, et al.
Clinical Nuclear Medicine|September 5, 2014
11C-choline PET/CT for restaging of bladder cancerTiziano Graziani, Francesco Ceci, Flavia Lobo Lopes, et al.
Clinical Nuclear Medicine|December 16, 2020
Novel Experience in Hybrid Tracers: Clinical Evaluation of Feasibility and Efficacy in Using ICG-99mTc Nanotop for Sentinel Node Procedure in Breast Cancer PatientsGianpiero Manca, Ludovico Maria Garau, Sara Mazzarri, et al.
Clinical Nuclear Medicine|February 3, 2015
SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approachR A Werner, Christina Bluemel, M Lassmann, et al.
Clinical Nuclear Medicine|February 3, 2021
Agreement Between 18F-FDG PET/CT and Whole-Body Magnetic Resonance Compared With Skeletal Survey for Initial Staging and Response at End-of-Treatment Evaluation of Patients With Multiple MyelomaNieves Gómez León, Beatriz Aguado Bueno, María Herreros Pérez, et al.
Clinical Nuclear Medicine|May 24, 2013
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT studyFrancesco Ceci, Riccardo Schiavina, Paolo Castellucci, et al.
Clinical Nuclear Medicine|December 26, 2015
18F-FDG PET/CT in the Initial Assessment and for Follow-up in Patients With TuberculosisIngrid Stelzmueller, Helmut Huber, Rainer Wunn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2013
Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapyAnna Margherita Maffione, Alice Ferretti, Gaia Grassetto, et al.
Clinical Nuclear Medicine|June 26, 2013
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mLMarcelo Mamede, Francesco Ceci, Paolo Castellucci, et al.
Pageof 23